A Randomized, Single-Blind, Group Sequential, Active-Controlled Study to Evaluate the Clinical Efficacy and Safety of α-Lipoic Acid for Critically Ill Patients With Coronavirus Disease 2019 (COVID-19)

OBJECT: To evaluate the clinical efficacy and safety of α-Lipoic acid (ALA) for critically ill patients with coronavirus disease 2019 (COVID-19). METHODS: A randomized, single-blind, group sequential, active-controlled trial was performed at JinYinTan Hospital, Wuhan, China. Between February 2020 an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Ming, Sun, Aijun, Xiao, Ting, Yao, Ge, Sang, Ling, Zheng, Xia, Zhang, Jinyan, Jin, Xuejuan, Xu, Lei, Yang, Wenlong, Wang, Peng, Hu, Kai, Zhang, Dingyu, Ge, Junbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854372/
https://www.ncbi.nlm.nih.gov/pubmed/35186959
http://dx.doi.org/10.3389/fmed.2021.566609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854372/
https://www.ncbi.nlm.nih.gov/pubmed/35186959
http://dx.doi.org/10.3389/fmed.2021.566609

Ejemplares similares